CRISPR-Cas9, a new chance for somatic gene therapy

被引：6
|
作者：
Jordan, Bertrand [1 ,2 ]
机构：
[1] Aix Marseille Univ, Hop Adultes Timone, Espace Eth Mediterraneen, EFS,CNRS,UMR ADES 7268, F-13385 Marseille 05, France
[2] CoReBio PACA, F-13288 Marseille 09, France
来源：
M S-MEDECINE SCIENCES | 2015年 / 31卷 / 11期
关键词：
D O I：
10.1051/medsci/20153111018
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Targeted modification of genes ("gene editing") is made much easier by the recently developed CRISPR-Cas9 system. This has raised alarm about possible uses of this technology for germline modification of the human genome; however this technology has less controversial applications, notably for somatic gene therapy with already some striking demonstrations in animal systems. Because of its precision and relative ease of use, CRISPR can be expected to drive a revolution in gene therapy and to turn it into a more mainstream approach.
引用
收藏
页码：1035 / 1038
页数：4
相关论文
共 50 条
  • [21] Safeguarding CRISPR-Cas9 gene drives in yeast
    DiCarlo, James E.
    Chavez, Alejandro
    Dietz, Sven L.
    Esvelt, Kevin M.
    Church, George M.
    NATURE BIOTECHNOLOGY, 2015, 33 (12) : 1250 - +
  • [22] Are we immune to Gene Scissors CRISPR-Cas9?
    不详
    DIABETOLOGE, 2019, 15 (01): : 42 - 42
  • [23] CRISPR-Cas9 gene editing for patients with haemoglobinopathies
    不详
    LANCET HAEMATOLOGY, 2019, 6 (09): : E438 - E438
  • [24] CRISPR-Cas9 for cancer therapy: Opportunities and challenges
    Chen, Minjiang
    Mao, Aiwu
    Xu, Min
    Weng, Qiaoyou
    Mao, Jianting
    Ji, Jiansong
    CANCER LETTERS, 2019, 447 : 48 - 55
  • [25] Base Editing of Somatic Cells Using CRISPR-Cas9 in Drosophila
    Marr, Elizabeth
    Potter, Christopher J.
    CRISPR JOURNAL, 2021, 4 (06): : 836 - 845
  • [26] CRISPR-Cas9 for selective targeting of somatic mutations in pancreatic cancers
    Teh, Selina Shiqing K.
    Bowland, Kirsten
    Halper-Stromberg, Eitan
    Kotwal, Akhil
    Bennett, Alexis
    Skaist, Alyza
    Tang, Jacqueline
    Cai, Fidel
    Macoretta, Antonella
    Liang, Hong
    Kamiyama, Hirohiko
    Wheelan, Sarah
    Lin, Ming-Tseh
    Hruban, Ralph H.
    Hung, Chien-Fu
    Goldstein, Michael
    Scharpf, Robert B.
    Roberts, Nicholas J.
    Eshleman, James R.
    NAR CANCER, 2024, 6 (02):
  • [27] CRISPR-Cas9 system: A new-fangled dawn in gene editing
    Gupta, Darshana
    Bhattacharjee, Oindrila
    Mandal, Drishti
    Sen, Madhab Kumar
    Dey, Dhritiman
    Dasgupta, Adhiraj
    Kazi, Tawsif Ahmed
    Gupta, Rahul
    Sinharoy, Senjuti
    Acharya, Krishnendu
    Chattopadhyay, Dhrubajyoti
    Ravichandiran, V.
    Roy, Syamal
    Ghosh, Dipanjan
    LIFE SCIENCES, 2019, 232
  • [28] Somatic Gene Therapy of Mucopolysaccharidosis with CRISPR/Cas9 Genome Editing
    Kao, Winston W. Y.
    Ferreira, Tarsis
    Dong, Fei
    Hu, Yueh-Chiang
    Call, Mindy Kay
    Coulson-Thomas, Vivien Jane
    Zhang, Jianhua
    Rice, Taylor
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [29] In Utero Fetal Therapy: Stem Cells, Cell Transplantation, Gene Therapy, and CRISPR-Cas9
    Shear, Matthew A.
    Massa, Andrew
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2021, 64 (04): : 861 - 875
  • [30] The new frontier of genome engineering with CRISPR-Cas9
    Doudna, Jennifer A.
    Charpentier, Emmanuelle
    SCIENCE, 2014, 346 (6213) : 1077 - +
12345